Aprogen KIC Acquires Aprogen Pharmaceutical Shares Worth 50 Billion KRW
[Asia Economy Reporter Minji Lee] Aprogen KIC announced on the 30th that it will acquire 33,333,334 shares of its affiliate Aprogen Pharmaceutical Co., Ltd. for 50 billion KRW. This corresponds to 9.48% of its equity capital. After the acquisition, the shareholding ratio based on the number of shares owned will be 31.26%.
Hot Picks Today
!["Not Everyone Can Afford This: Inside the World of the True Top 0.1% [Luxury World]"](https://cwcontent.asiae.co.kr/asiaresize/93/2026051507261063923_1778797570.png)
"Not Everyone Can Afford This: Inside the World of the True Top 0.1% [Luxury World]"
- While All Eyes Were on Samsung and Hynix, This Company Surged 50% to New Highs in Four Days [Weekend Money]
- "Now Our Salaries Are 10 Million Won a Month" Record High... Semiconductor Boom Drives Performance Bonuses at Major Electronic Component Firms
- "Sold Out Everywhere" The Surprising Story of the 'Purple Gold' Philippine Yam That Has Captivated the World [Delicious Stories]
- Experts Already Watching Closely..."Target Price Set at 970,000 Won" Only Upward Momentum Remains [Weekend Money]
The acquisition method is cash acquisition through participation in a rights offering to existing shareholders, and the purpose of the acquisition is investment in new business.
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
